CRISPR trial for inherited blindness underway

Editas Medicine and Allergan are teaming up to conduct the first human trial of a CRISPR gene-editing therapy for inherited blindness.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553